Federico Maggi

Ikonisys, Inc. designs and manufactures medical diagnostic products for the diagnosis of cancers. Its products include Ikoniscope Robotic Microscope that provides automated slide handling, slide scanning, real-time image capture and analysis, eliminates various factors that cause human error in testing, oncoFISH bladder that allows scanning and analysis of cells recovered from a voided urine sample. The company was founded by Pramod K. Srivastava, Petros Tsipouras, Gamil G. de Chadarevian, Michael W. Kilpatrick and Triantafyllos Tafas in 1999 and is headquartered in New Haven, CT.

Impact Lab SRL provides oncology diagnosis services. The company was founded by Vittorio Grazioli in September 2015 and is headquartered in Milan, Italy.

HeartGenetics, Genetics & Biotechnology SA operates as a biotech company that develops genetic tests and computational tools designed to support clinical diagnosis and the prevention of cardiovascular diseases. Its genetic testing kits include Clopidogrel PGX, TromboGene Kit, Warfarin PGX, Simvastatin PGX, and DNArterial Kit. The company was founded by Ana Teresa Freitas and Susana Santos in April 2013 and is headquartered in Cantanhede, Portugal.

Humanitas SpA owns and manages hospitals. It also provides diagnostic, therapeutic and rehabilitative services. The company was founded by Gianfelice Mario Rocca in 1988 and is headquartered in Rozzano, Italy.

Centro Diagnostico Italiano SpA is a Milan-based outpatient healthcare facility that has been in operation for over 45 years. The Italian company offers a range of services including prevention, diagnosis, and therapy. The private company also organizes and sponsor scientific training events for medical professionals. Additionally, they provide radiology exams such as ultrasounds, biopsies, and guided needle aspirations. Centro Diagnostico Italiano offers a family card for all companies and businesses that are directly affiliated with their occupational health and check-up services. The CEO of the company is Diana Bracco.